Pharmacy News
January 4, 2021
December 31, 2020
December 20, 2020
December 29, 2020
December 23, 2020
December 18, 2020
December 17, 2020
- Leukemia Drug Recalled
- Chemo Injection Recalled
- Chemotherapy Tablets Recalled
- Chemotherapy Drug Recalled
December 10, 2020
December 9, 2020
- AvKARE Issues Voluntary Nationwide Recall of Sildenafil 100mg Tablets and Trazodone 100mg Tablets Due to Product Mix-Up
- Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Anagrelide Capsules, USP Due to Dissolution Test Failure
December 3, 2020
December 2, 2020
November 25, 2020
November 19, 2020
November 13, 2020
November 9, 2020
November 6, 2020
November 3, 2020
November 2, 2020
October 28, 2020
October 17, 2020
October 16, 2020
October 8, 2020
October 5, 2020
September 23, 2020
September 21, 2020
September 18, 2020
- Subpotent Antibiotic Recalled
- Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
September 9, 2020
September 3, 2020
- Class I Recall for Anticoagulant
- Antibiotic Recalled
- Narcotic Pain Injection Recalled
- Consumer-Level Recall of Nature-Throid® and WP Thyroid® Tablets Manufactured by RLC Labs®
September 1, 2020
August 28, 2020
August 26, 2020
- Sanofi-Aventis U.S. LLC
- Lannett Company, Inc.
- The Calvin Scott & Company:
August 21, 2020
August 19, 2020
- SCA Pharmaceuticals (SCA) Is Issuing a Voluntary Nationwide Recall of Heparin Sodium Compounded Products Due to Incorrect Preservative (Benzyl Alcohol)
- Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
August 14, 2020
August 7, 2020
August 6, 2020
July 29, 2020
July 24, 2020
July 23, 2020
July 14, 2020
July 9, 2020
- Two More Firms Recall Diabetes Drug
- Two Children’s Meds Recalled
- Braun Recalling Heparin Products
On July 9, 2020, CVS Caremark Mail Service received a consumer-level withdrawal notice from McKesson regarding Heparin Sodium in 5% Dextrose Injection manufactured by B Braun Medical Inc. This withdrawal was issued as part of ongoing changes which BBMI is performing to ensure their Heparin in Dextrose products meet USP requirements for Anti-Factor IIa potency throughout the labeled product shelf-life, BBMI is incorporating revisions to internal manufacturing requirements. Out of an abundance of caution, BBMI is withdrawing non-expired batches of those Heparin in Dextrose products which were produced prior to implementation of these changes. This withdrawal affects select Heparin Sodium in 5% Dextrose Injection products. - Osteoarthritis Injection Recalled
July 8, 2020
- Mylan Initiates Voluntary Nationwide Recall of One Lot of Daptomycin for Injection, Due to The Presence of Particulate
- Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
July 6, 2020
July 2, 2020
- Diabetes Drug Recall Grows
- Label Mistake Prompts Antipsychotic Recall
- Major Pharmaceuticals Issues a Consumer-Level Recall of Metformin Extended-Release Tablets
On July 2, 2020, it was announced that Major Pharmaceuticals issued a consumer-level recall on Metformin Hydrochloride Extended-Release 500mg Tablets, 10×10 Unit Dose with NDC #00904-5794-61. The recall was issued due to one lot of Metformin being tested and showed results for NDMA levels in excess of the Acceptable Daily Intake Limit. This recall affects lot number T-02134 with expiration date 09/2020.
June 26, 2020
June 19, 2020
- GSK Consumer Healthcare Issues Voluntary Nationwide Recall of Children’s Robitussin® Honey Cough and Chest Congestion DM and Children’s Dimetapp® Cold and Cough Due to Dosing Cups Missing Some Graduation Markings
- Class I, II Recalls for Pain Injection
- Antibiotic Pills Recalled
June 17, 2020
June 12, 2020
June 11, 2020
- Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of One Lot of Metformin Hydrochloride Extended-Release Tablets USP, 500mg Due to the Detection of N-Nitrosodimethylamine (NDMA)
- AvKARE Issues Consumer-Level Recall of Metformin Hydrochloride Extended-Release 500mg and 750mg Tablets
June 5, 2020
- Marksans Pharma Limited Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg, Due to the Detection of N-Nitrosodimethylamine (NDMA)
- Teva Pharmaceuticals USA, Inc. Initiates Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets USP 500 mg and 750 mg Due to Detection of N-Nitrosodimethylamine (NDMA)
June 3, 2020
June 2, 2020
June 1, 2020
May 28, 2020
May 27, 2020
May 22, 2020
May 15, 2020
May 12, 2020
May 11, 2020
May 8, 2020
- ICU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer’s Injection, USP Due to the Presence of Particulate Matter
- Class I Recall Issued for Intravenous Antibiotic
- CU Medical Issues a Voluntary Nationwide Recall of Lactated Ringer’s Injection, USP Due to the Presence of Particulate Matter
- Antacid Recalled
May 1, 2020
April 29, 2020
April 24, 2020
April 21, 2020
- Voluntary Recall Notice for BD PosiFlush™ SF Saline Flush Syringes
- B. Braun Medical Inc. Issues Voluntary Nationwide Recall of One (1) Lot of Ceftazidime for Injection USP and Dextrose Injection USP (50 mL), Duplex Container Due to Out-of-Specification Results for High Molecular Weight Polymers
- Trividia Health, Inc. Issues Nationwide Voluntary Recall for an Isolated TRUE METRIX AIR Blood Glucose Meter with Serial Number TA1548753
April 20, 2020
- Fresenius Kabi Issues Voluntary Nationwide Recall of 13 Lots of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter in Reserve Samples
- Avet Pharmaceuticals Voluntarily Issues Recall of 50mg Losartan Potassium Tablets Due to Failed Dissolution Specifications
- Avet Pharmaceuticals Voluntarily Issues Recall of 100mg Losartan Potassium Tablets Due to Failed Dissolution Specifications
April 17, 2020
April 15, 2020
- Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Nizatidine Oral Solution, 15 mg/mL, Due to Potential Levels of N-nitrosodimethylamine (NDMA) Impurity Amounts Above the Levels Established by FDA
- International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Clopidogrel Tablets USP, 75 mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A
April 9, 2020
April 3, 2020
April 1, 2020
March 27, 2020
- Dr. Reddy’s Laboratories Issues Voluntary Nationwide Recall of Phytonadione Injectable Emulsion USP, 10 mg/mL Single-Dose Ampules Due To Ampules Breaking And Shattering Upon Opening
- Antibiotic Recalled
- Stimulant Patches Recalled
March 24, 2020
March 20, 2020
March 13, 2020
March 5, 2020
February 28, 2020
February 27, 2020
February 24, 2020
February 21, 2020
- Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5ml Due to Possible Underdosing or Overdosing
- Cholesterol, Blood Pressure Med Recalled
- Antibiotic Recalled
February 14, 2020
February 13, 2020
February 12, 2020
January 31, 2020
- Antacid Recalls Grow
- Efficient Laboratories, Inc. Issues Voluntary Nationwide Recall of Rompe Pecho EX, Rompe Pecho CF, and Rompe Pecho MAX due to Microbial Contamination